Glaukos price target lowered to $115 from $140 at Stephens

Stephens lowered the firm’s price target on Glaukos (GKOS) to $115 from $140 and keeps an Overweight rating on the shares after the company delivered Q1 results that exceeded consensus but fell below investor expectations. iDose sequential growth trends and domestic iStent growth will need to accelerate for shares to re-rate higher, the analyst tells investors in a post-earnings note.